Anaqua
IP management platform (AQX) for docketing, renewals, and portfolio administration, with AI modules for patent classification, redundancy detection, and competitive landscape reporting.
This is where the depth lives — everything below is evidence-graded
How the product is positioned
IP management platform (AQX) for docketing, renewals, and portfolio administration, with AI modules for patent classification, redundancy detection, and competitive landscape reporting.
Our summary of the vendor’s positioning — verbatim claim not yet recordedWhat we found
Level 1 · assistive
Seeded at the rubric default. No independent evidence of end-to-end task completion has been reviewed yet, so the lowest grade applies until it is.
Any human checkpoint here is a product setting, not a regulatory requirement — confirm how it is configured for your deployment.
Graded 2026-08-01 · re-check 2026-11-01
Procurement detail
- Deployment
- saasvendor documentation
- Compliance
- SOC 2 Type IIreport dates not disclosed — request before signing
- Integrations
- PatSnap (partnership for pharma IP) claim unverified
- Pricing
- platform-licenseCustom enterprise pricing; not publicly listed.
- Human checkpoint
- Requiredproduct setting
Will they still be here?
- Funding
- Privately held; backed by growth equity investors (undisclosed structure)
- Founded
- 2004
- HQ
- Boston, USA
Sources
Logo retrieved 2026-08-01from the vendor’s own site · trademark of Anaqua, Inc.
- anaqua.comVendor-published · retrieved 2026-08-01
- anaqua.comVendor-published · retrieved 2026-08-01
Every source here is vendor-published. That is why this entry is not graded high confidence.
Where it’s weak
Stronger as an administrative/docketing system of record than as a pure analytics/search tool compared to PatSnap.
Corrections
Vendors may submit factual corrections free of charge. We correct facts and publish the change. We do not accept payment to change a grade. Submit a correction →